▶ 調査レポート

世界の特許医薬品市場 2021:企業別、地域別、種類・用途別

• 英文タイトル:Global Patent Medicine Market 2021 by Company, Regions, Type and Application, Forecast to 2026

GlobalInfoResearchが調査・発行した産業分析レポートです。世界の特許医薬品市場 2021:企業別、地域別、種類・用途別 / Global Patent Medicine Market 2021 by Company, Regions, Type and Application, Forecast to 2026 / GIR-107A15059資料のイメージです。• レポートコード:GIR-107A15059
• 出版社/出版日:GlobalInfoResearch / 2021年7月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、82ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、特許医薬品のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。特許医薬品の種類別市場規模(製品特許、プロセス特許)、用途別市場規模(大人、子供)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・特許医薬品の市場概要
・企業情報(企業概要、製品概要、販売量、価格、売上):Pfizer Inc.、Otsuka Pharmaceutical、Merck、Novartis、Sanofi-Aventis、Bristol-Myers Squibb Co.、GSK
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:製品特許、プロセス特許
・用途別分析2016年-2026年:大人、子供
・特許医薬品の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・特許医薬品のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・特許医薬品のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・特許医薬品の南米市場規模2016年-2026年:ブラジル、アルゼンチン
・特許医薬品の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Patent Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Patent Medicine size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Patent Medicine market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Patent Medicine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Product Patents
Process Patents

Market segment by Application, can be divided into
Adult
Children

Market segment by players, this report covers
Pfizer Inc.
Otsuka Pharmaceutical
Merck
Novartis
Sanofi-Aventis
Bristol-Myers Squibb Co.
GSK

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Patent Medicine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Patent Medicine, with revenue, gross margin and global market share of Patent Medicine from 2019 to 2021.
Chapter 3, the Patent Medicine competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Patent Medicine market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Patent Medicine research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 Product Overview and Scope of Patent Medicine
1.2 Classification of Patent Medicine by Type
1.2.1 Overview: Global Patent Medicine Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Patent Medicine Revenue Market Share by Type in 2020
1.2.3 Product Patents
1.2.4 Process Patents
1.3 Global Patent Medicine Market by Application
1.3.1 Overview: Global Patent Medicine Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Adult
1.3.3 Children
1.4 Global Patent Medicine Market Size & Forecast
1.5 Global Patent Medicine Market Size and Forecast by Region
1.5.1 Global Patent Medicine Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Patent Medicine Market Size by Region, (2016-2021)
1.5.3 North America Patent Medicine Market Size and Prospect (2016-2026)
1.5.4 Europe Patent Medicine Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Patent Medicine Market Size and Prospect (2016-2026)
1.5.6 South America Patent Medicine Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Patent Medicine Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Patent Medicine Market Drivers
1.6.2 Patent Medicine Market Restraints
1.6.3 Patent Medicine Trends Analysis
2 Company Profiles
2.1 Pfizer Inc.
2.1.1 Pfizer Inc. Details
2.1.2 Pfizer Inc. Major Business
2.1.3 Pfizer Inc. Patent Medicine Product and Solutions
2.1.4 Pfizer Inc. Patent Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Pfizer Inc. Recent Developments and Future Plans
2.2 Otsuka Pharmaceutical
2.2.1 Otsuka Pharmaceutical Details
2.2.2 Otsuka Pharmaceutical Major Business
2.2.3 Otsuka Pharmaceutical Patent Medicine Product and Solutions
2.2.4 Otsuka Pharmaceutical Patent Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Otsuka Pharmaceutical Recent Developments and Future Plans
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Patent Medicine Product and Solutions
2.3.4 Merck Patent Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Merck Recent Developments and Future Plans
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Patent Medicine Product and Solutions
2.4.4 Novartis Patent Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Novartis Recent Developments and Future Plans
2.5 Sanofi-Aventis
2.5.1 Sanofi-Aventis Details
2.5.2 Sanofi-Aventis Major Business
2.5.3 Sanofi-Aventis Patent Medicine Product and Solutions
2.5.4 Sanofi-Aventis Patent Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Sanofi-Aventis Recent Developments and Future Plans
2.6 Bristol-Myers Squibb Co.
2.6.1 Bristol-Myers Squibb Co. Details
2.6.2 Bristol-Myers Squibb Co. Major Business
2.6.3 Bristol-Myers Squibb Co. Patent Medicine Product and Solutions
2.6.4 Bristol-Myers Squibb Co. Patent Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Bristol-Myers Squibb Co. Recent Developments and Future Plans
2.7 GSK
2.7.1 GSK Details
2.7.2 GSK Major Business
2.7.3 GSK Patent Medicine Product and Solutions
2.7.4 GSK Patent Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 GSK Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Patent Medicine Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Patent Medicine Players Market Share
3.2.2 Top 10 Patent Medicine Players Market Share
3.2.3 Market Competition Trend
3.3 Patent Medicine Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Patent Medicine Revenue and Market Share by Type (2016-2021)
4.2 Global Patent Medicine Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Patent Medicine Revenue Market Share by Application (2016-2021)
5.2 Patent Medicine Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Patent Medicine Revenue by Type (2016-2026)
6.2 North America Patent Medicine Revenue by Application (2016-2026)
6.3 North America Patent Medicine Market Size by Country
6.3.1 North America Patent Medicine Revenue by Country (2016-2026)
6.3.2 United States Patent Medicine Market Size and Forecast (2016-2026)
6.3.3 Canada Patent Medicine Market Size and Forecast (2016-2026)
6.3.4 Mexico Patent Medicine Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Patent Medicine Revenue by Type (2016-2026)
7.2 Europe Patent Medicine Revenue by Application (2016-2026)
7.3 Europe Patent Medicine Market Size by Country
7.3.1 Europe Patent Medicine Revenue by Country (2016-2026)
7.3.2 Germany Patent Medicine Market Size and Forecast (2016-2026)
7.3.3 France Patent Medicine Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Patent Medicine Market Size and Forecast (2016-2026)
7.3.5 Russia Patent Medicine Market Size and Forecast (2016-2026)
7.3.6 Italy Patent Medicine Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Patent Medicine Revenue by Type (2016-2026)
8.2 Asia-Pacific Patent Medicine Revenue by Application (2016-2026)
8.3 Asia-Pacific Patent Medicine Market Size by Region
8.3.1 Asia-Pacific Patent Medicine Revenue by Region (2016-2026)
8.3.2 China Patent Medicine Market Size and Forecast (2016-2026)
8.3.3 Japan Patent Medicine Market Size and Forecast (2016-2026)
8.3.4 South Korea Patent Medicine Market Size and Forecast (2016-2026)
8.3.5 India Patent Medicine Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Patent Medicine Market Size and Forecast (2016-2026)
8.3.7 Australia Patent Medicine Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Patent Medicine Revenue by Type (2016-2026)
9.2 South America Patent Medicine Revenue by Application (2016-2026)
9.3 South America Patent Medicine Market Size by Country
9.3.1 South America Patent Medicine Revenue by Country (2016-2026)
9.3.2 Brazil Patent Medicine Market Size and Forecast (2016-2026)
9.3.3 Argentina Patent Medicine Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Patent Medicine Revenue by Type (2016-2026)
10.2 Middle East & Africa Patent Medicine Revenue by Application (2016-2026)
10.3 Middle East & Africa Patent Medicine Market Size by Country
10.3.1 Middle East & Africa Patent Medicine Revenue by Country (2016-2026)
10.3.2 Turkey Patent Medicine Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Patent Medicine Market Size and Forecast (2016-2026)
10.3.4 UAE Patent Medicine Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Patent Medicine Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Patent Medicine Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Patent Medicine Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Patent Medicine Revenue (USD Million) by Region (2016-2021)
Table 5. Global Patent Medicine Revenue Market Share by Region (2021-2026)
Table 6. Pfizer Inc. Corporate Information, Head Office, and Major Competitors
Table 7. Pfizer Inc. Major Business
Table 8. Pfizer Inc. Patent Medicine Product and Solutions
Table 9. Pfizer Inc. Patent Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Otsuka Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 11. Otsuka Pharmaceutical Major Business
Table 12. Otsuka Pharmaceutical Patent Medicine Product and Solutions
Table 13. Otsuka Pharmaceutical Patent Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Merck Corporate Information, Head Office, and Major Competitors
Table 15. Merck Major Business
Table 16. Merck Patent Medicine Product and Solutions
Table 17. Merck Patent Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Novartis Corporate Information, Head Office, and Major Competitors
Table 19. Novartis Major Business
Table 20. Novartis Patent Medicine Product and Solutions
Table 21. Novartis Patent Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Sanofi-Aventis Corporate Information, Head Office, and Major Competitors
Table 23. Sanofi-Aventis Major Business
Table 24. Sanofi-Aventis Patent Medicine Product and Solutions
Table 25. Sanofi-Aventis Patent Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Bristol-Myers Squibb Co. Corporate Information, Head Office, and Major Competitors
Table 27. Bristol-Myers Squibb Co. Major Business
Table 28. Bristol-Myers Squibb Co. Patent Medicine Product and Solutions
Table 29. Bristol-Myers Squibb Co. Patent Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. GSK Corporate Information, Head Office, and Major Competitors
Table 31. GSK Major Business
Table 32. GSK Patent Medicine Product and Solutions
Table 33. GSK Patent Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Global Patent Medicine Revenue (USD Million) by Players (2019-2021)
Table 35. Global Patent Medicine Revenue Share by Players (2019-2021)
Table 36. Breakdown of Patent Medicine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 37. Patent Medicine Players Head Office, Products and Services Provided
Table 38. Patent Medicine Mergers & Acquisitions in the Past Five Years
Table 39. Patent Medicine New Entrants and Expansion Plans
Table 40. Global Patent Medicine Revenue (USD Million) by Type (2016-2021)
Table 41. Global Patent Medicine Revenue Share by Type (2016-2021)
Table 42. Global Patent Medicine Revenue Forecast by Type (2021-2026)
Table 43. Global Patent Medicine Revenue by Application (2016-2021)
Table 44. Global Patent Medicine Revenue Forecast by Application (2021-2026)
Table 45. North America Patent Medicine Revenue by Type (2016-2021) & (USD Million)
Table 46. North America Patent Medicine Revenue by Type (2021-2026) & (USD Million)
Table 47. North America Patent Medicine Revenue by Application (2016-2021) & (USD Million)
Table 48. North America Patent Medicine Revenue by Application (2021-2026) & (USD Million)
Table 49. North America Patent Medicine Revenue by Country (2016-2021) & (USD Million)
Table 50. North America Patent Medicine Revenue by Country (2021-2026) & (USD Million)
Table 51. Europe Patent Medicine Revenue by Type (2016-2021) & (USD Million)
Table 52. Europe Patent Medicine Revenue by Type (2021-2026) & (USD Million)
Table 53. Europe Patent Medicine Revenue by Application (2016-2021) & (USD Million)
Table 54. Europe Patent Medicine Revenue by Application (2021-2026) & (USD Million)
Table 55. Europe Patent Medicine Revenue by Country (2016-2021) & (USD Million)
Table 56. Europe Patent Medicine Revenue by Country (2021-2026) & (USD Million)
Table 57. Asia-Pacific Patent Medicine Revenue by Type (2016-2021) & (USD Million)
Table 58. Asia-Pacific Patent Medicine Revenue by Type (2021-2026) & (USD Million)
Table 59. Asia-Pacific Patent Medicine Revenue by Application (2016-2021) & (USD Million)
Table 60. Asia-Pacific Patent Medicine Revenue by Application (2021-2026) & (USD Million)
Table 61. Asia-Pacific Patent Medicine Revenue by Region (2016-2021) & (USD Million)
Table 62. Asia-Pacific Patent Medicine Revenue by Region (2021-2026) & (USD Million)
Table 63. South America Patent Medicine Revenue by Type (2016-2021) & (USD Million)
Table 64. South America Patent Medicine Revenue by Type (2021-2026) & (USD Million)
Table 65. South America Patent Medicine Revenue by Application (2016-2021) & (USD Million)
Table 66. South America Patent Medicine Revenue by Application (2021-2026) & (USD Million)
Table 67. South America Patent Medicine Revenue by Country (2016-2021) & (USD Million)
Table 68. South America Patent Medicine Revenue by Country (2021-2026) & (USD Million)
Table 69. Middle East & Africa Patent Medicine Revenue by Type (2016-2021) & (USD Million)
Table 70. Middle East & Africa Patent Medicine Revenue by Type (2021-2026) & (USD Million)
Table 71. Middle East & Africa Patent Medicine Revenue by Application (2016-2021) & (USD Million)
Table 72. Middle East & Africa Patent Medicine Revenue by Application (2021-2026) & (USD Million)
Table 73. Middle East & Africa Patent Medicine Revenue by Country (2016-2021) & (USD Million)
Table 74. Middle East & Africa Patent Medicine Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Patent Medicine Picture
Figure 2. Global Patent Medicine Revenue Market Share by Type in 2020
Figure 3. Product Patents
Figure 4. Process Patents
Figure 5. Patent Medicine Revenue Market Share by Application in 2020
Figure 6. Adult Picture
Figure 7. Children Picture
Figure 8. Global Patent Medicine Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 9. Global Patent Medicine Revenue and Forecast (2016-2026) & (USD Million)
Figure 10. Global Patent Medicine Revenue Market Share by Region (2016-2026)
Figure 11. Global Patent Medicine Revenue Market Share by Region in 2020
Figure 12. North America Patent Medicine Revenue (USD Million) and Growth Rate (2016-2026)
Figure 13. Europe Patent Medicine Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Asia-Pacific Patent Medicine Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. South America Patent Medicine Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Middle East and Africa Patent Medicine Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Patent Medicine Market Drivers
Figure 18. Patent Medicine Market Restraints
Figure 19. Patent Medicine Market Trends
Figure 20. Pfizer Inc. Recent Developments and Future Plans
Figure 21. Otsuka Pharmaceutical Recent Developments and Future Plans
Figure 22. Merck Recent Developments and Future Plans
Figure 23. Novartis Recent Developments and Future Plans
Figure 24. Sanofi-Aventis Recent Developments and Future Plans
Figure 25. Bristol-Myers Squibb Co. Recent Developments and Future Plans
Figure 26. GSK Recent Developments and Future Plans
Figure 27. Global Patent Medicine Revenue Share by Players in 2020
Figure 28. Patent Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 29. Global Top 3 Players Patent Medicine Revenue Market Share in 2020
Figure 30. Global Top 10 Players Patent Medicine Revenue Market Share in 2020
Figure 31. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 32. Global Patent Medicine Revenue Share by Type in 2020
Figure 33. Global Patent Medicine Market Share Forecast by Type (2021-2026)
Figure 34. Global Patent Medicine Revenue Share by Application in 2020
Figure 35. Global Patent Medicine Market Share Forecast by Application (2021-2026)
Figure 36. North America Patent Medicine Sales Market Share by Type (2016-2026)
Figure 37. North America Patent Medicine Sales Market Share by Application (2016-2026)
Figure 38. North America Patent Medicine Revenue Market Share by Country (2016-2026)
Figure 39. United States Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Canada Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Mexico Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Europe Patent Medicine Sales Market Share by Type (2016-2026)
Figure 43. Europe Patent Medicine Sales Market Share by Application (2016-2026)
Figure 44. Europe Patent Medicine Revenue Market Share by Country (2016-2026)
Figure 45. Germany Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. France Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. United Kingdom Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Russia Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Italy Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Asia-Pacific Patent Medicine Sales Market Share by Type (2016-2026)
Figure 51. Asia-Pacific Patent Medicine Sales Market Share by Application (2016-2026)
Figure 52. Asia-Pacific Patent Medicine Revenue Market Share by Region (2016-2026)
Figure 53. China Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Japan Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. South Korea Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. India Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Southeast Asia Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Australia Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. South America Patent Medicine Sales Market Share by Type (2016-2026)
Figure 60. South America Patent Medicine Sales Market Share by Application (2016-2026)
Figure 61. South America Patent Medicine Revenue Market Share by Country (2016-2026)
Figure 62. Brazil Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Argentina Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Middle East and Africa Patent Medicine Sales Market Share by Type (2016-2026)
Figure 65. Middle East and Africa Patent Medicine Sales Market Share by Application (2016-2026)
Figure 66. Middle East and Africa Patent Medicine Revenue Market Share by Country (2016-2026)
Figure 67. Turkey Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Saudi Arabia Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. UAE Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Methodology
Figure 71. Research Process and Data Source